CLDND1 Antikörper (Middle Region)
Kurzübersicht für CLDND1 Antikörper (Middle Region) (ABIN951560)
Target
Alle CLDND1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 50-80, Middle Region
-
Spezifität
- This antibody reacts to CLDND1.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human and Mouse.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 50~80 amino acids from the Central region of human CLDND
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CLDND1 (Claudin Domain Containing 1 (CLDND1))
-
Andere Bezeichnung
- CLDND1
-
Hintergrund
- CLDND1 is widely distributed in the adult CNS with highest expression in the corpus callosum, caudate nucleus, cerebral cortex, medulla, putamen, spinal cord, substantia nigra and subthalamic nucleus. Weak expression has been detected in the adult heart. There are 2 named isoforms produced by alternative splicing.Synonyms: C3orf4, Claudin domain-containing protein 1, GENX-3745, HSPC174, PRO6000, PSEC0054, UNQ2511
-
Molekulargewicht
- 28603 Da
-
Gen-ID
- 56650
-
NCBI Accession
- NP_001035271
Target
-